In a recent study, ETV6/RUNX1 fusion in a B-ALL model was knocked out using the CRISPR-Cas9 system, causing an enhanced level of apoptosis and reduced proliferation rate. Here, RUNX1 is linked to acute lymphoblastic leukemia.